Eyevensys raised $30M in a round led by Boehringer Ingelheim Venture Fund Biotech Health services Manufacturing Investments 18 January 2020 Share:
Round value (USD): 30m Round investors: Boehringer Ingelheim Venture Fund Bpifrance Karista Pureos Bioventures Quark Venture Inserm Transfert Initiative Company: Eyevensys Industry: Biotech Health services Manufacturing
Biolog-id raised €30M from Xerys. Biotech Competitive Intelligence Health services Software Services Investments 09 November 2019